If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Directorate Change

13 Mar 2006 07:02

Stanelco PLC13 March 2006 13th March 2006 Stanelco plc ("Stanelco" or the "Company") Appointment of new Finance Director Stanelco plc, the RF applications group, is pleased to announce the appointmentof Clive Warner as Finance Director. Mr Warner will commence his appointmenttoday replacing Mr Robert Boardman who leaves the Company today to pursue hisown business interests. Clive Warner, age 53, joins Stanelco from NAAFI, a global provider of retail,leisure and catering services to the Armed Forces, where he has served asFinance Director since 2002. Clive is a Chartered Accountant who gained themajority of his business experience in the retail and leisure sectors includingwith Sears, Woolworth and UCI Cinemas. Clive will continue to serve as FinanceDirector at Naafi before focusing full-time on his new role at Stanelco whichwill be by 1 July 2006 at the latest. Clive has been a non-executive director of Mygard plc since April 2004. There isno additional disclosure required pursuant to Listing Rule 9.6.13. Martin Wagner, Chief Executive, Stanelco plc commented: "I am delighted thatClive is joining our Board, his track record and wealth of experience willstrengthen the Company as we commercialise our technologies. I would also liketo thank Rob Boardman for his contribution towards the Company over the pastyear and wish him success in his future endeavours." Clive Warner, Finance Director, Stanelco plc commented: "I am looking forward tothe exciting challenge at Stanelco and contributing towards its future success." Stanelco has today granted options to the trustees of the Stanelco Plc EmployeeBenefit Trust (EBT) to acquire (by way of subscription) 10,000,000 ordinaryshares in the capital of the Company for an exercise price of 15.18 pence pershare. The Director's and Persons Discharging Managerial Responsibility (PDMR)are interested in these options. Stanelco intends, in due course, to issue aletter of wishes in respect of these share options to the trustees of the EBTasking them to consider appointing these share options to sub trusts for thebenefit of Mr Martin Wagner his spouse, widow, children or stepchildren underthe age of 18 years old (in respect of an option over 5,000,000 shares at anexercise price of 15.18 pence per share lapsing 12 March 2016) and for thebenefit of Mr Clive Warner his spouse, widow, children or stepchildren under theage of 18 years old (in respect of an option over 5,000,000 shares at anexercise price of 15.18 pence per share lapsing 12 March 2016). The appointmentof these share options into the proposed sub-trusts is at the discretion of thetrustees of the EBT and further announcement will be made should they choose toact on the letter of wishes. Robert Boardman continues to hold an option over 1,402,525 shares issued underthe EMI (Enterprise Management Incentive) scheme, but his interest in 6,097,475share options held under the EBT lapses on cessation of his employment. Including the options over 10,000,000 shares granted to the EBT today there areoptions over 33,292,683 shares which have been granted by the Company to theEBT. In addition to the above notification in respect of the 10,000,000 sharessubject to the options granted to the trustees of the EBT today, the Companyconfirms that EBT holds share options on behalf of the Director's, PDMR andemployees as follows. For the benefit of Mr Ian Balchin and his family an optionover 8,000,000 shares at an exercise price of 10.25 pence per share lapsing 3February 2015, for the benefit of Mr Howard White and his family an option over7,024,390 shares at an exercise price of 10.25 pence per share lapsing 3February 2015, for the benefit of Mr Robert Duggan and his family an option over2,268,293 shares at an exercise price of 10.25 pence per share lapsing 3February 2015, for the benefit of Mr Harald Schmidt and his spouse, children andstepchildren under the age of 18 years old an option over 5,000,000 shares at anexercise price of 19 pence per share lapsing 22 July 2015 and for the benefit ofMr Martin Wagner and his family an option over 1,000,000 shares at an exerciseprice of 19 pence per share lapsing 7 August 2015. - Ends - For further information please contact: Ian Balchin, Executive Vice ChairmanStanelco PLCTel: +44 (0)2380 867 100 Jonathon Brill/Billy CleggFinancial DynamicsTel: +44 (0)20 7831 3113 About Stanelco plc The Stanelco Group of companies (the Group) has brought together expertise inradio frequency (RF) technology, RF applications and biodegradable materialsciences to create a revolutionary range of packaging technologies. Stanelco's philosophy is that new products and processes must offer solutionsand applications which: - give higher added value, - are greener, more environmentally sustainable than those they replace and - have protectable intellectual property rights. Stanelco will develop the products and processes to a demonstration stage andthen work with partners in order to reach the markets; and under thesecircumstances Stanelco will usually seek to license its technology. Stanelcoinvests considerable time and resources in ensuring its technologies areprotected via layers of patents wherever possible. In this way Stanelco believes it can minimise commercial risk and preserve thehighest value for shareholders. The products offering the prospect of near term revenue generation are beinggiven priority over the Group's resources. Stanelco was founded in 1953 and is a world leader in the development of radiofrequency technologies for processing polymers for edible and packagingapplications and the design and manufacture of optical fibre technology,induction heating and dielectric welding equipment. Stanelco's currentdevelopments include GREENSEAL Food tray lidding technology, STARPOL (starch /pva blended material), STARPOL 2000 (highly functional, low cost biodegradablepackaging material with food contact approvals) FrogPack high impact low costpackaging format, CradleWrap range of biodegradable air cushion packaging,Soluble tape, 100% water-soluble films and adhesives, Biodegradable Airbag (voidfill) packaging, edible hard-shell capsule technology, water-soluble detergentcapsules, edible sachets and waste packing. GREENSEAL, STARPOL, FrogPack and CradleWrap are all trademarks of the Stanelcoplc group. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jan 20157:00 amRNSOperational Update
22nd Jan 20157:00 amRNSPre-close Trading Statement
21st Jan 20154:35 pmRNSHolding(s) in Company
11th Dec 201410:11 amRNSChange of Adviser
14th Nov 20149:58 amRNSHolding(s) in Company
4th Nov 20147:00 amRNSTrading Update
3rd Sep 20147:00 amRNSInterim Results
12th Aug 20149:36 amRNSHolding(s) in Company
31st Jul 20147:00 amRNSContract progress for RF Technologies Business
24th Jul 20143:28 pmRNSTrading Update
6th Jun 20143:56 pmRNSHolding(s) in Company
7th May 20147:00 amRNSEMI Share Option Plan
23rd Apr 201412:26 pmRNSResult of AGM and Appointment of Director
23rd Apr 20147:00 amRNSTrading Update
31st Mar 20147:00 amRNSUpdated Corporate Presentation
28th Mar 20147:02 amRNSPosting of Notice of AGM & Annual Report
27th Mar 20147:00 amRNSPreliminary Results
24th Mar 201411:43 amRNSContract for Stanelco RF Technologies Division
19th Feb 20149:01 amRNSHolding(s) in Company
24th Jan 20147:00 amRNSPre-close Trading Statement
4th Dec 20133:37 pmRNSIssue of Shares to Director
28th Nov 20131:30 pmRNSDirector/PDMR Shareholding
27th Nov 20137:00 amRNSHolding(s) in Company
4th Nov 20137:00 amRNSTrading Update
31st Oct 201312:27 pmRNSTotal Voting Rights
2nd Oct 201312:47 pmRNSIssue of Shares to a Director
27th Sep 20138:51 amRNSTR-1: Notification of Major Interest in Shares
25th Sep 201312:33 pmRNSResult of General Meeting
2nd Sep 20137:10 amRNSNotice of General Meeting
2nd Sep 20137:00 amRNSInterim Results
26th Jul 20137:00 amRNSPurchase of Shares following Consolidation
18th Jul 20137:00 amRNSInterim Management Statement
20th Jun 20132:34 pmRNSIssue of Equity
20th Jun 201312:45 pmRNSResult of General Meeting
17th Jun 201312:01 pmRNSHolding(s) in Company
17th Jun 201311:59 amRNSHolding(s) in Company
23rd May 20137:01 amRNSCapital Reorganisation
23rd May 20137:00 amRNSSettlement with Landlord in Respect of Leases
26th Apr 20137:00 amRNSIssue of shares to a Director Total Voting rights
25th Apr 20134:10 pmRNSResult of AGM
25th Apr 20137:00 amRNSTrading Update
4th Apr 20137:00 amRNSResearch Grant Award
3rd Apr 20134:35 pmRNSNotice of AGM and Annual Report and Accounts
28th Mar 20137:10 amRNSDirector's Remuneration and Consultancy agreement
28th Mar 20137:01 amRNSPreliminary Results
23rd Jan 20137:00 amRNSPre-close Trading Statement
2nd Nov 20127:00 amRNSTrading Update
1st Oct 20123:24 pmRNSCompletion of Sale
27th Sep 20122:03 pmRNSResult of General Meeting
7th Sep 20127:00 amRNSProposed Sale of stake in Biotec Holding GmbH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.